Cargando…
10031-RT-02 Results of reactor-based BNCT for 44 cases of recurrent and refractory high-grade meningiomas and road to accelerator based BNCT
Introduction: High-grade meningioma (HGM) is difficult clinical entity to treat. Especially recurrent HGM after some radiotherapy has very miserable prognosis. For example median overall survival (mOS) of recurrent HGM after radiotherapy is reported as 2 years. We applied tumor-selective particle ra...
Autores principales: | Miyatake, Shin-Ichi, Kawabata, Shinji, Wanibuchi, Masahiko, Takai, Satoshi, Takeuchi, Koji, Ono, Koji, Ko, Naonori, Sakurai, Yoshinori, Tanaka, Hiroki, Suzuki, Minoru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699070/ http://dx.doi.org/10.1093/noajnl/vdaa143.047 |
Ejemplares similares
-
RT-06 PLANNING OF BORON NEUTRON CAPTURE THERAPY (BNCT) USING POSITRON EMISSION TOMOGRAPHY (PET)
por: Kawabata, Shinji, et al.
Publicado: (2019) -
Reactor-based boron neutron capture therapy for 44 cases of recurrent and refractory high-grade meningiomas with long-term follow-up
por: Takai, Satoshi, et al.
Publicado: (2021) -
ACT-02 BORON NEUTRONS CAPTURE THERAPY FOR RECURRENT HIGH-GRADE MENINGIOMAS, FROM REACTOR TO ACCELERATOR
por: Miyatake, Shin-Ichi, et al.
Publicado: (2019) -
Dose Rate Effect on Cell Survival in BNCT
por: Hirose, Katsumi, et al.
Publicado: (2023) -
Accelerator-based BNCT for patients with recurrent glioblastoma: a multicenter phase II study
por: Kawabata, Shinji, et al.
Publicado: (2021)